VENOCCLUSIVE DISEASE OF THE LIVER AFTER CHEMORADIOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATION1
- 1 June 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 43 (6) , 870-873
- https://doi.org/10.1097/00007890-198743060-00020
Abstract
We determined the incidence of venocclusive disease of the liver (VOD) in 96 recipients of autologous bone marrow transplants (BMT) to be 9.4%, a figure less than that reported for allogeneic transplantation. The development of VOD was compared in a cohort of 21 autologous BMT recipients and in 56 randomly chosen, comparably conditioned, concurrent allogeneic BMT recipients. One of these 21 (4.8%) autologous recipients developed VOD, versus 14 of 56 (25%) allogeneic recipients (PThis publication has 3 references indexed in Scilit:
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing FactorsHepatology, 1984
- An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantationGastroenterology, 1980